Investor Presentaiton

78 Doubling of revenue from 2015 base Consistent >40% segment EBITDA margins(1) Target 2022 2x GDP Growth in pavement, oilfield, agriculture and lubricants Long-Range Target Post-patent pathway to growth Revenues ~$1.5 billion Mid-20s % segment EBITDA margins(1) Top quartile specialty chemicals franchise (1) Please see appendices included at the end of this presentation for Ingevity's use of non-GAAP financial measures, definitions of those financial measures as well as the reconciliation to the nearest GAAP financial measure. Adjusted EBITDA(1) ~$500 million Adjusted EBITDA(1) Margin >30% Ingevity

View entire presentation